These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 6674913)
1. Fluctuations in steady-state phenytoin concentrations as measured in saliva in children. Aman MG; Paxton JW; Werry JS Pediatr Pharmacol (New York); 1983; 3(2):87-94. PubMed ID: 6674913 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of toxic anticonvulsant drug concentrations in mentally retarded persons with epilepsy. Aman MG; Paxton JW; Field CJ; Foote SE Am J Ment Defic; 1986 May; 90(6):643-50. PubMed ID: 3717220 [TBL] [Abstract][Full Text] [Related]
3. Influence of bioavailability on the calculated Michaelis-Menten parameters of phenytoin in children. Koren G; Brand N; MacLeod SM Ther Drug Monit; 1984; 6(1):11-4. PubMed ID: 6710554 [TBL] [Abstract][Full Text] [Related]
4. Oral phenytoin in infancy: dose requirement, absorption, and elimination. Albani M; Wernicke I Pediatr Pharmacol (New York); 1983; 3(3-4):229-36. PubMed ID: 6677874 [TBL] [Abstract][Full Text] [Related]
5. [Determination of phenytoin in saliva and its clinical significance]. Schmidt D Bibl Psychiatr; 1975; (151):49-54. PubMed ID: 1156348 [No Abstract] [Full Text] [Related]
6. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Perucca E; Cloyd J; Critchley D; Fuseau E Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564 [TBL] [Abstract][Full Text] [Related]
7. [Meta-analysis of the Italian studies on short-term effects of air pollution]. Biggeri A; Bellini P; Terracini B; Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188 [TBL] [Abstract][Full Text] [Related]
8. Apparent Michaelis-Menten kinetic parameters of phenytoin in pediatric patients. Chiba K; Ishizaki T; Miura H; Minagawa K Pediatr Pharmacol (New York); 1980; 1(2):171-80. PubMed ID: 7346739 [TBL] [Abstract][Full Text] [Related]
9. Effect of piperine on the steady-state pharmacokinetics of phenytoin in patients with epilepsy. Pattanaik S; Hota D; Prabhakar S; Kharbanda P; Pandhi P Phytother Res; 2006 Aug; 20(8):683-6. PubMed ID: 16767797 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study. Ebid AH; Ahmed MM; Mohammed SA Ther Drug Monit; 2007 Jun; 29(3):305-12. PubMed ID: 17529887 [TBL] [Abstract][Full Text] [Related]
11. Phenytoin dosage requirements and pharmacokinetic variables. Taylor JW; Murphy MJ; Berg MJ; Perry PJ; Lyon LW; Ludden TM Clin Pharm; 1983; 2(3):253-7. PubMed ID: 6883953 [TBL] [Abstract][Full Text] [Related]
12. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients. Yegnanarayan R; Mahesh SD; Sangle S Chronobiol Int; 2006; 23(5):1035-46. PubMed ID: 17050216 [TBL] [Abstract][Full Text] [Related]
13. Kinetics of intravenous phenytoin in children. Koren G; Brand N; Halkin H; Dany S; Shahar E; Barzilay Z Pediatr Pharmacol (New York); 1984; 4(1):31-8. PubMed ID: 6739185 [TBL] [Abstract][Full Text] [Related]
14. Bioavailability of phenytoin sodium capsules available in Thailand. Part II: In vivo study. Suthisisang C; Payakachat N; Chulavatnatol S; Towanabut S J Med Assoc Thai; 1998 Jan; 81(1):64-70. PubMed ID: 9470324 [TBL] [Abstract][Full Text] [Related]
15. Correlation between serum and salivary phenytoin concentrations in Thai epileptic children. Liamsuwan S; Jaiweerawattana U J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S172-7. PubMed ID: 22043772 [TBL] [Abstract][Full Text] [Related]
16. Does it really matter when a blood sample for valproic acid concentration is taken following once-daily administration of divalproex-ER? Reed RC; Dutta S Ther Drug Monit; 2006 Jun; 28(3):413-8. PubMed ID: 16778728 [TBL] [Abstract][Full Text] [Related]
17. Salivary phenytoin concentrations in epilepsy and in chronic renal failure. Reynolds F; Ziroyanis PN; Jones NF; Smith SE Lancet; 1976 Aug; 2(7982):384-6. PubMed ID: 73850 [TBL] [Abstract][Full Text] [Related]
18. Phenytoin therapy for epileptic children: evaluation of salivary and plasma concentrations and of methods of assessing compliance. Zysset T; Rüdeberg A; Vassella F; Küpfer A; Bircher J Dev Med Child Neurol; 1981 Feb; 23(1):66-75. PubMed ID: 6781961 [TBL] [Abstract][Full Text] [Related]
19. Effects of phenytoin on cognitive-motor performance in children as a function of drug concentration, seizure type, and time of medication. Aman MG; Werry JS; Paxton JW; Turbott SH Epilepsia; 1994; 35(1):172-80. PubMed ID: 8112242 [TBL] [Abstract][Full Text] [Related]
20. Salivary free concentrations of anti-epileptic drugs: an evaluation in a routine clinical setting. al Za'abi M; Deleu D; Batchelor C Acta Neurol Belg; 2003 Mar; 103(1):19-23. PubMed ID: 12704979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]